New Webinar: Optimizing Analytics for Biosimilars

How Providing Comprehensive Data Can Accelerate Drug Development

Glasgow, UK – April 21, 2016: Sartorius Stedim BioOutsource today announced that its scientific experts will be presenting a live webinar about optimizing biosimilar analysis on Thursday, June 2, at 3 pm BST, 10 am EDT. The webinar is essential listening for researchers who want to understand how to select optimal clones and processes to accelerate development of their biosimilars.

During the one-hour webinar, Dr. Martin De Cecco, and Dr. Terry Gray will explore the impact of differing glycan structures on antibody function using a case study comparing biosimilar infliximab to the innovator molecule Remicade®. Drawing on real-life examples, both experts will discuss a variety of orthogonal methods, including glycan analysis by LC-MS, CD16a and SPR binding, as well as ADCC activity that will highlight the benefits of performing combined structural and functional analysis. They will also be discussing the importance of choosing appropriate analytical assays at each stage of the product’s development and how utilizing a comprehensive testing package can provide evidence suitable for regulatory submissions to enable biosimilars to enter clinical programs more rapidly.

To register for this informative webinar and receive a recording to listen to on demand, scientists should click the link:

http://ow.ly/4mVIAp

Dr. Daniel Galbraith, Chief Scientific Officer of Sartorius Stedim BioOutsource, stated: “The complex nature of monoclonal antibodies often results in differences between the biosimilar and innovator molecule and the key to regulatory acceptance is understanding the potential clinical significance of those residual differences. We’re delighted to be hosting a webinar during which our experts will explain how generating comprehensive characterization data for the regulators can overcome reservations about a new monoclonal, to deliver faster and more cost-effective biosimilar drug development.”

For further information, please contact:

Gemma Fulton, Marketing Manager

1 Technology Terrace, Todd Campus, West of Scotland Science Park,
Glasgow, United Kingdom, G20 0XA
Tel: +44 (0)141 946 4222 | Fax: +44(0)141 946 4552